US2021220514A1PendingUtilityA1

Kits for preparing a reactive graft material and injecting the graft material into a patient

65
Assignee: AGNOVOS HEALTHCARE LLCPriority: Dec 13, 2013Filed: Mar 31, 2021Published: Jul 22, 2021
Est. expiryDec 13, 2033(~7.4 yrs left)· nominal 20-yr term from priority
A61L 24/02C04B 35/447A61L 27/12A61L 2400/06A61L 27/02A61L 27/56A61L 2430/02A61L 27/3641A61L 27/54A61L 2300/102A61L 2300/414A61L 2300/112A61L 27/3847C04B 28/34C04B 28/14A61L 2300/10A61L 24/0015C04B 2111/00836A61L 27/3821A61L 27/3608A61L 27/58A61L 27/025
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are kits for preparing a reactive graft material and injecting the graft material into a patient. Kits may include a first syringe containing a first powdered component and a second syringe containing a second powdered component that is reactive with the first powdered component when the first and second powdered components are dispersed in a diluent solution. The kits may further include a vial sealed by a septum and containing the diluent solution. A syringe connector may be included that has a connector at each end configured to make a fluidic connection to, respectively, the first syringe and the second syringe, and also comprises a passageway adapted to allow fluid to pass between the syringes when the syringes are both fluidically connected to the syringe connector. A vial adapter comprising a connector adapted for fluidically connecting to at least one of the first syringe and the second syringe, a passageway adapted to allow fluid to pass from the vial into a syringe fluidically connected to the connector of the vial adapter, and a spike in fluidic communication with the passageway of the vial adapter may be included. The spike is adapted for piercing the septum of the vial. Certain kits also contain one or more needles for delivery of the graft material to a site within a body of a patient.

Claims

exact text as granted — not AI-modified
1 . A kit for preparing a reactive graft material and injecting the graft material into a patient, comprising:
 a first syringe containing a first powdered component;   a second syringe containing a second powdered component that is reactive with the first powdered component when the first and second powdered components are dispersed in a diluent solution;   a vial containing the diluent solution and sealed by a septum;   a syringe connector that includes a connector at each end configured to make a fluidic connection to, respectively, the first syringe and the second syringe, and also comprises a passageway adapted to allow fluid to pass between the syringes when the syringes are both fluidically connected to the syringe connector;   a vial adapter comprising a connector adapted for fluidically connecting to at least one of the first syringe and the second syringe, a passageway adapted to allow fluid to pass from the vial into a syringe fluidically connected to the connector of the vial adapter, and a spike in fluidic communication with the passageway of the vial adapter, wherein the spike is adapted for piercing the septum of the vial; and   one or more needles for delivery of the graft material to a site within a body of a patient.   
     
     
         2 . The kit of  claim 1 , wherein the connectors at each end of the syringe connector are threaded connectors. 
     
     
         3 . The kit of  claim 2 , wherein the connector of the vial adapter is a threaded connector. 
     
     
         4 . The kit of  claim 1 , further comprising at least two needles. 
     
     
         5 . The kit of  claim 4 , wherein the at least two needles comprise needles that differ from one another in length and/or gauge. 
     
     
         6 . The kit of  claim 4 , wherein at least one needle is a Jamshidi needle. 
     
     
         7 . The kit of  claim 6 , wherein each of the one or more needles is a Jamshidi needle. 
     
     
         8 . The kit of  claim 6 , comprising an 11-gauge Jamshidi needle of a first length and a 16-gauge Jamshidi needle of a second, shorter length.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.